Activating mutations in the Ki-ras2 oncogene are frequently observed in sporadic colorectal adenomas and their incidence is reported to rise in large and tubulovillous adenomas to values close to those in carcinomas. This study shows that this property is a feature of adenomas growing in large bowel
Ki-ras mutations in adenomas from cancer-bearing and cancer-freee bowel
β Scribed by Zauber, N. Peter; Sabbath-Solitaire, Marlene; Bishop, D. Timothy
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 19 KB
- Volume
- 184
- Category
- Article
- ISSN
- 0022-3417
No coin nor oath required. For personal study only.
β¦ Synopsis
We read with interest the paper by Morris et al. 1 reporting a higher incidence of Ki-ras oncogene mutations in villous or tubulovillous adenomas removed from cancer-bearing bowel as opposed to cancer-free bowel. Our calculation of the odds ratio for their data is 3β’125. They found the higher percentage of mutations in adenomas from cancer-bearing bowel to be largely attributable to adenomas recovered from patients over 70 years of age.
We have evaluated a cohort of patients with sporadic colorectal polyps and cancer. All patients had had complete colonoscopies, thus ensuring proper identification as to cancer-bearing or cancer-free bowel. We analysed 188 adenomas and 52 carcinomas for mutations in codons 12/13 of the Ki-ras gene using singlestrand conformational polymorphism polyacrylamide electrophoresis. We derived the odds ratio and 95 per cent confidence intervals and used a two-sided chi-square test for the level of significance. This is a more conservative test than the one-sided test used by Morris et al.
For all adenomas, we found a 2β’6-fold increased risk for a mutation in adenomas from cancer-bearing bowel compared with adenomas from cancer-free bowel, when adjusted for histology, P<0β’02 (Table I). When we controlled for age less than or greater than 70 years, we found a 3β’2-fold increased risk for Ki-ras mutation in
π SIMILAR VOLUMES
Mutations in the Ki-ras oncogene and the p53 tumor suppressor gene are known to occur at high frequencies in human colon cancers. We measured the frequency of mutations in these two genes in colon adenocarcinomas obtained from a widely used experimental model of human colon carcinogenesis: F344 rats
The aims of this study were (i) to assess the prevalence and spectrum of codon 12 Ki-ras mutations in patients diagnosed with exocrine pancreatic cancer (EPC) in 2 general hospitals between 1980 and 1990, (ii) to analyze the association of this genetic alteration with clinical and pathological chara
## Abstract A transplacental carcinogenicity study was conducted by exposing pregnant Swiss (CDβ1) mice to 0, 50, 100, 200, or 300 mg 3β²βazidoβ3β²βdeoxythymidine (AZT)/kg body weight (BW) daily for the duration of gestation (18β19 days) [National Toxicology Program,2006]. The incidence of alveolar/b